EHU049871
MISSION® esiRNA
targeting human CD109
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
NACRES:
NA.51
UNSPSC Code:
41105324
description
Powered by Eupheria Biotech
Quality Level
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
TGCTGACTTGGAGAGCAGAACAAGAAGGTGGCATGCAATTCTGGGTGTCATCAGAGTCCAAACTTTCTGACTCCTGGCAGCCACGCTCCCTGGATATTGAAGTTGCAGCCTATGCACTGCTCTCACACTTCTTACAATTTCAGACTTCTGAGGGAATCCCAATTATGAGGTGGCTAAGCAGGCAAAGAAATAGCTTGGGTGGTTTTGCATCTACTCAGGATACCACTGTGGCTTTAAAGGCTCTGTCTGAATTTGCAGCCCTAATGAATACAGAAAGGACAAATATCCAAGTGACCGTGACGGGGCCTAGCTCACCAAGTCCTGTAAAGTTTCTGATTGACACACACAACCGCTTACTCCTTCAGACAGCAGAGCTTGCTGTGGTACAGCCAACGGCAGTTA
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Gene Information
human ... CD109(135228)
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
Storage Class
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Xue-Tang Mo et al.
British journal of cancer, 123(5), 833-843 (2020-06-09)
CD109 was involved in the tumorigenesis and progression of various cancers via TGF-β1 signalling and STAT3 activation. As CD109 is strongly expressed in cervical squamous cell carcinoma, this study was conducted to investigate its functional characteristics in cervical cancer. CD109
Guijuan Zong et al.
Digestive diseases and sciences, 61(8), 2303-2314 (2016-04-15)
Hepatocellular carcinoma (HCC) accounts for 75-80 % of primary liver cancer, and usually arises after years of liver disease. Thus it is important to understand the molecular mechanisms which drive or mediate the development of HCC. In this work, we examined
Global Trade Item Number
| SKU | GTIN |
|---|---|
| EHU049871-50UG | 04061828335923 |
| EHU049871-20UG | 04061828571161 |